Liver Diseases  >>  IDX21459  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IDX21459 / Merck (MSD)
NCT02112942: Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects

Terminated
1
48
Canada
IDX21459, Matching Placebo
Merck Sharp & Dohme LLC
Chronic Hepatitis C
06/14
06/14

Download Options